Abdominal and intra-abdominal fibromatoses: Outcomes over time
Our data suggest that a combination of less morbid surgical approaches and the addition of nonsurgical approaches (active disease surveillance, use of tyrosine kinase inhibitors and other interventions) have resulted in substantially fewer surgical interventions over time for intra-abdominal and abdominal wall fibromatoses treated between 2009 and 2023. The overall probability of recurrences, however, in patients treated surgically remains similar.
Authors
- Andrew E. Rosenberg (ORCID: https://orcid.org/0000-0002-4536-8824)
- Gina Z. D’Amato (ORCID: https://orcid.org/0000-0001-6981-7527)
- Temitope Kehinde
- Diego Montoya‐Cerrillo (ORCID: https://orcid.org/0000-0002-8557-7014)
- Mónica Sánchez-Ávila (ORCID: https://orcid.org/0000-0002-0200-5142)
- Fireneh N. Beshah
- Domenika Ortiz Requena (ORCID: https://orcid.org/0000-0002-8827-6794)
- Alan S. Livingstone (ORCID: https://orcid.org/0000-0003-2102-5795)
- Francis J. Hornicek (ORCID: https://orcid.org/0000-0002-6916-8042)
- Amr Abulaban (ORCID: https://orcid.org/0009-0004-1822-5109)
- Elizabeth A. Montgomery (ORCID: https://orcid.org/0000-0001-9788-8218)
Institutions
- University of Miami (US)
- Jackson Memorial Hospital (US)
- Sylvester Comprehensive Cancer Center (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1093/ajcp/aqae182
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00